MARATTO

article · Aquaculture Reports

Antimicrobial efficacy of magnetite nanoparticles against Aeromonas sobria challenge in African catfish: Biochemical, protein profile, and immuno-antioxidant indices

202318 citationsOpen accessUniversity of Sadat City

Abstract

Recently, researchers in aquaculture become interested in green synthesized nanomaterials as a superior alternative to current conventional methodologies. The present work shows that Moringa oleifera synthesized magnetite nanoparticles (MS-Fe3O4NPs) might offer a possible substitute for common antibiotics to treat Aeromonas sobria infection in African catfish (Clarias gariepinus). MS-Fe3O4NPs demonstrated an in vitro antibacterial potential (21 mm inhibition zone) against A. sobria. The fish (n = 120; average body weight: 90 ± 3.5 g) were randomized into four groups (control, MS-Fe3O4NPs, A. sobria, and MS-Fe3O4NPs + A. sobria), where 1.2 mg/L of MS-Fe3O4NPs was used as bath treatment for seven-days. A. sobria infection caused substantial elevations in malondialdehyde, tumor necrosis factor-alpha, stress indices, and hepato-renal biomarkers as well as a lower survival rate. Moreover, an apparent depletion in the level of antioxidants, the protein profile, and immune indicators were the consequences of A. sobria infection. Surprisingly, treatment of A. sobria-infected fish with MS-Fe3O4NPs recovered these parameters. Hence, MS-Fe3O4NPs as a water additive show promise as an antibacterial treatment against A. sobria in fish.

Research topics

  • Moringa oleifera research and applications
  • Aquaculture disease management and microbiota
  • Aquaculture Nutrition and Growth

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1016/j.aqrep.2023.101692

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.